Table 1.
Laboratory findings.
| White blood cells | 5,700/μL | Total protein | 6.7 g/dL |
| Neutrophils | 77.9% | Albumin | 3.3 g/dL |
| Eosinophils | 0.2% | Total bilirubin | 1.5 mg/dL |
| Basophils | 0.4% | Na | 140 mEq/L |
| Monocytes | 9.6% | K | 4.2 mEq/L |
| Lymphocytes | 11.9% | Cl | 102 mEq/L |
| Red blood cells | 533 × 104/μL | Ca | 13.6 mg/dL |
| Hemoglobin | 17.3 g/dL | BUN | 13 mg/dL |
| Hematocrit | 50.8% | Creatinine | 0.66 mg/dL |
| Platelet count | 23.2 × 104/μL | Uric acid | 9.3 mg/dL |
| Coagulation | Total cholesterol | 227 mg/dL | |
| PT | 11.3 sec | Glucose | 112 mg/dL |
| APTT | 36.0 sec | Amylase | 22 IU/L |
| Fibrinogen | 201 mg/dL | CRP | 0.52 mg/dL |
| FDP | 19.9 μg/mL | TPHA | Negative |
| AST | 37 U/L | HBs Ag | Negative |
| ALT | 6 U/L | HCV Ab | Negative |
| LDH | 622 U/L | HIV Ab | Negative |
| ALP | 222 U/L | HTLV-1 Ab | Positive |
| GGT | 18 U/L | sIL-2R | 27,500 U/mL |
Abbreviations: PT: prothrombin time; APTT: activated partial thromboplastin time; FDP: fibrin/fibrinogen degradation product; AST: aspartate aminotransferase; ALT: alanine aminotransferase; LDH: lactate dehydrogenase; ALP: alkaline phosphatase; GGT: γ-glutamyltransferase; BUN: blood urea nitrogen; CRP: C-reactive protein; TPHA: treponema pallidum hemagglutination test; HBs Ag: hepatitis B virus s antigen; HCV Ab: hepatitis C virus antibody; HIV Ab: human immunodeficiency virus antibody; HTLV-1 Ab: human T-cell leukemia virus type 1 antibody; sIL-2R: soluble interleukin-2 receptor.